Voxcell Bioinnovation Inc.: federal grants and contributions: 11 agreements; $1.4M value; 3 departments; 6 programs.
Assay record ASY-CA-10ACPIF1J6 · Cite as: Assay Systems, “Voxcell Bioinnovation Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/voxcell-bioinnovation-inc/
The project is focused on the development of human-like cancer tissue models as a more reliable preclinical testing platform for oncology drugs than what is presently available.
As part of the international consortium project “Bioprinted Platform of Next Generation Cancer Models with Human-Like Vascularization for Preclinical Drug Development”, this project will validate a 3D bioprinted tissue model platform as a viable tool for the development of personalized cell therapies and identify therapeutic T-Cell candidates for further development.
The project aims to integrate induced pluripotent stem cell-derived endothelial precursor cells (EPCs) into high resolution 3D printed human tissue models.
This International Co-Innovation Action Program (ICAP) project will prepare the firm to enter into future international co-innovation work.
To provide employment for a recent graduate of biomedical engineering.
This project aims to develop software capable of creating complex tissue models for 3D bioprinting. The software will generate files of 3D human-like cancer tissue structures containing a complex blood vessel network.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
Through the application of national and local priorities, the CSJ program seeks to provide youth, particularly those who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Participation in the Canadian medical biotechnology co-innovation mission to the Eureka Global Innovation Summit and Swiss Biotech Day in Switzerland – May 3 to 8, 2026. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop international partnerships and potential project ideas under the Eureka Programs.
Participation in Canada–UK biomanufacturing peer‑to‑peer networking meetings – June 8 to 15, 2026. Through the 2023 Canada–UK Biomanufacturing Initiative (Memorandum of Cooperation), Canada and the United Kingdom committed to advancing collaboration in biomanufacturing, with a focus on co‑innovation, workforce development, and scale‑up. The initiative includes the creation of a bilateral peer‑to‑peer network that brings together experts and organizations from both countries to strengthen partnerships and pursue shared growth opportunities.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.